NCT02641782 2022-11-04
NB2013-HR
University of Cologne
Phase 2 Terminated
Clinical Trials
3 trialsNCT01048086 2016-06-21
90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)
University of Iowa
Phase 2 Withdrawn
NCT00001509 2008-03-04
A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor
National Institutes of Health Clinical Center (CC)
Phase 2 Completed